康寧醫院(02120.HK)2019年營收同比增15.38%至8.61億元
格隆匯3月31日丨康寧醫院(02120.HK)公佈2019年度全年業績,報告期內,公司實現營業收入8.61億元人民幣(單位下同),同比增長15.38%;歸屬於公司股東的淨利潤5728.9萬元。基本每股收益0.78元。
2019年,國家醫療保障局實施一系列醫保控費改革措施,包括藥品4+7帶量採購試點和醫保支付方式改革等,集團積極調整策略以適應醫保監管要求,在保障醫療服務質量的同時,完善並調整收費結構,控制醫療費用。具體取得以下進展:
2019年,集團自有醫院業務發展平穩。2018年開業的杭州怡寧醫院、台州康寧醫院和路橋慈寧醫院以及控股式併購的温嶺南方醫院、南京怡寧醫院、冠縣怡寧醫院和菏澤怡寧醫院業務發展步入正軌。集團成熟醫院業務發展平穩,平陽康寧醫院和老年醫院的服務量較去年同期增長較快。
2019年下半年,蒼南康寧醫院搬遷至新大樓並投入營運,新增300張牀位,青田康寧醫院、永嘉康寧醫院由於場地空間約束,業務發展受限,但該等醫院已在實施新院區遷建工程,預計將新增500張牀位。截至2019年12月31日,集團自有醫院增至21家(2018年12月31日:18家),運營牀位數增至6,073張(2018年12月31日:5140張)。此外,為了將優勢精力用於自有醫院發展,集團進一步縮減管理諮詢業務,並不再將其作為主營業務核算和報告。
2019年,集團信息化水平進一步提升,初步實現了精神專科醫院一系列核心系統的自主研發和自有版權,並正式對外銷售。此外,集團還與加拿大專家共建海外院士工作站,致力於開展人工智能領域研究和醫學臨牀教育的合作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.